Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.

Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L.

J Cereb Blood Flow Metab. 2007 Mar;27(3):552-63. Epub 2006 Jul 12.

PMID:
16835629
[PubMed - indexed for MEDLINE]
2.

Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.

Lapchak PA, Kirkeby A, Zivin JA, Sager TN.

Brain Res. 2008 Oct 31;1238:208-14. doi: 10.1016/j.brainres.2008.08.017. Epub 2008 Aug 16.

PMID:
18761001
[PubMed - indexed for MEDLINE]
3.

Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.

Liu W, Shen Y, Plane JM, Pleasure DE, Deng W.

Exp Neurol. 2011 Aug;230(2):227-39. doi: 10.1016/j.expneurol.2011.04.021. Epub 2011 May 6.

PMID:
21596035
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A neuroprotective derivative of erythropoietin that is not erythropoietic.

Doggrell SA.

Expert Opin Investig Drugs. 2004 Nov;13(11):1517-9.

PMID:
15500399
[PubMed - indexed for MEDLINE]
5.

High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).

Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjørn SE, Gerwien J, Leist M.

Thromb Haemost. 2008 Apr;99(4):720-8. doi: 10.1160/TH07-03-0208.

PMID:
18392330
[PubMed - indexed for MEDLINE]
6.

Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia.

Hewlett KA, Corbett D.

Neuroscience. 2006 Aug 11;141(1):27-33. Epub 2006 May 11. Erratum in: Neuroscience. 2007 Mar 30;145(3):1182.

PMID:
16690215
[PubMed - indexed for MEDLINE]
7.

Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.

Montero M, Poulsen FR, Noraberg J, Kirkeby A, van Beek J, Leist M, Zimmer J.

Exp Neurol. 2007 Mar;204(1):106-17. Epub 2006 Dec 8.

PMID:
17157835
[PubMed - indexed for MEDLINE]
8.

Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.

King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT.

Eur J Neurosci. 2007 Jul;26(1):90-100.

PMID:
17614942
[PubMed - indexed for MEDLINE]
9.

Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.

Wakida K, Shimazawa M, Hozumi I, Satoh M, Nagase H, Inuzuka T, Hara H.

Neuroscience. 2007 Aug 10;148(1):105-14. Epub 2007 Jul 12.

PMID:
17624681
[PubMed - indexed for MEDLINE]
10.

Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia.

Schäbitz WR, Berger C, Kollmar R, Seitz M, Tanay E, Kiessling M, Schwab S, Sommer C.

Stroke. 2004 Apr;35(4):992-7. Epub 2004 Feb 26.

PMID:
14988579
[PubMed - indexed for MEDLINE]
Free Article
11.

Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats.

Wen TC, Rogido M, Peng H, Genetta T, Moore J, Sola A.

Neuroscience. 2006;139(3):803-11. Epub 2006 Apr 3.

PMID:
16581190
[PubMed - indexed for MEDLINE]
12.

Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats.

Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, Guiba-Tziampiri O.

Brain Res. 2005 May 31;1045(1-2):22-30.

PMID:
15910759
[PubMed - indexed for MEDLINE]
13.

Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.

Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A.

Brain Res. 2002 Sep 20;950(1-2):268-78.

PMID:
12231253
[PubMed - indexed for MEDLINE]
14.

Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.

Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A, Lu M, Pool C, Heavner G, Chopp M.

Br J Pharmacol. 2007 Aug;151(8):1377-84. Epub 2007 Jul 2.

PMID:
17603558
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.

Lumenta DB, Plesnila N, Kläsner B, Baethmann A, Pruneau D, Schmid-Elsaesser R, Zausinger S.

Brain Res. 2006 Jan 19;1069(1):227-34. Epub 2005 Dec 27.

PMID:
16378603
[PubMed - indexed for MEDLINE]
16.

Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.

Grasso G, Sfacteria A, Erbayraktar S, Passalacqua M, Meli F, Gokmen N, Yilmaz O, La Torre D, Buemi M, Iacopino DG, Coleman T, Cerami A, Brines M, Tomasello F.

J Neurosurg Spine. 2006 Apr;4(4):310-8.

PMID:
16619678
[PubMed - indexed for MEDLINE]
17.

Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats.

Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J.

Stroke. 2007 Oct;38(10):2795-803. Epub 2007 Aug 16.

PMID:
17702962
[PubMed - indexed for MEDLINE]
Free Article
18.

Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?

Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S.

Int J Urol. 2008 Oct;15(11):1011-7. doi: 10.1111/j.1442-2042.2008.02149.x. Epub 2008 Aug 26.

PMID:
18759748
[PubMed - indexed for MEDLINE]
19.

Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.

Adembri C, Massagrande A, Tani A, Miranda M, Margheri M, De Gaudio R, Pellegrini-Giampietro DE.

Crit Care Med. 2008 Mar;36(3):975-8. doi: 10.1097/CCM.0B013E3181644343.

PMID:
18176311
[PubMed - indexed for MEDLINE]
20.

The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.

Garcia-Rodriguez JC, Sosa-Teste I.

ScientificWorldJournal. 2009 Sep 15;9:970-81. doi: 10.1100/tsw.2009.103. Review.

PMID:
19768354
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk